Microbix Presents HCV Testing Quality Controls at EMMD

PUBT · 6d ago
Microbix Presents HCV Testing Quality Controls at EMMD
  • Microbix Biosystems will attend the European Meeting on Molecular Diagnostics in Noordwijk, the Netherlands, Nov. 4-6, 2026.
  • Its poster presentation will focus on synthetic DNA- and RNA-based quality controls for point-of-need and laboratory hepatitis C testing.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbix Biosystems Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202611020700ACCESSWRNAPR_____1244749) on November 02, 2026, and is solely responsible for the information contained therein.